A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe-Reference-Cited by-同舟云学术

A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe

Published:2024-05-08 Issue:5 Volume:24 Page:687-695
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Dzingirai Blessing¹²^ORCID,Katsidzira Leolin³,Mwanesani Vongai²,Postma Maarten Jacobus¹,van Hulst Marinus¹⁴,Mafirakureva Nyashadzaishe⁵

Affiliation:

1. Unit of Global Health, Department of Health Sciences, Üniversity of Groningen, University Medical Center Groningen, Groningen, The Netherlands

2. Department of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe

3. Department of Medicine, College of Health Sciences University of Zimbabwe, Harare, Zimbabwe

4. Department of Clinical Pharmacy and Toxicology, Martini Hospital, Groningen, The Netherlands

5. Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2024.2348055

Reference38 articles.

1. World Health Organization. Global health sector strategies on respectively, HIV, viral hepatitis, and sexually transmitted infection for the period 2022-2030. Geneva (Switzerland): World Health Organization (WHO); 2022.

2. World Health Organization. Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and diagnostics. Geneva (Switzerland): WHO; 2022.

3. A path to eradication of hepatitis C in low- and middle-income countries

4. Access to HCV treatments: hurdles not barriers

5. Crunching the numbers for viral hepatitis